Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial
Pharma
Novartis pledges nearly $480M to bolster China production, R&D
Amid a spate of pharma investments in China, Novartis is the latest drugmaker lining up to bolster its R&D and production operations in the country.
Fraiser Kansteiner
Mar 23, 2026 10:35am
BioMarin halts dosing, enrollment in 3 midstage Voxzogo studies
Mar 16, 2026 11:26am
Safety signals prompt Ipsen to withdraw cancer med Tazverik
Mar 9, 2026 10:07am
Another setback for Enspryng as Roche halts Duchenne development
Feb 23, 2026 3:40pm
Merck seeks Enflonsia expansion to rival Sanofi, AZ's Beyfortus
Feb 19, 2026 10:40am
Pfizer confirms patient death in hemophilia drug trial
Dec 23, 2025 11:05am
